One of the latest updates in ROS-exploiting cancer therapy, in fact, identifies iron as an amplifier of ROS signaling to induce pyroptosis (a lytic programmed cell death initiated by inflammasomes), via the Tom20/Bax/caspase-3-cleaved gasdermin E (GSDME) pathway in melanoma cells [115]. The gene discussed is GSDME; the disease is melanoma.